Prognostic value of 18F-choline PET/CT metabolic parameters in patients with metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide.
Eur J Nucl Med Mol Imaging
; 45(3): 348-354, 2018 03.
Article
in En
| MEDLINE
| ID: mdl-29110067
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Phenylthiohydantoin
/
Choline
/
Prostatic Neoplasms, Castration-Resistant
/
Positron Emission Tomography Computed Tomography
/
Androstenes
Type of study:
Observational_studies
/
Prognostic_studies
Limits:
Adult
/
Aged
/
Aged80
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Eur J Nucl Med Mol Imaging
Journal subject:
MEDICINA NUCLEAR
Year:
2018
Document type:
Article
Affiliation country:
Italy
Country of publication:
Germany